A new analysis calculates the ideal waiting time between combined chemotherapy and radiation for rectal cancer and surgical removal of the cancer.
US regulators approved Arzerra, to be used as an extended treatment against recurrent or progressive chronic lymphocytic leukemia.
A new study reveals that young adult and adolescent cancer survivors, especially men, worry about their fertility and genetic risk factors.
Treating patients with advanced rectal cancer with short-course radiation followed by consolidation chemotherapy before surgery led to positive outcomes.
Everolimus increased median progression-free survival in patients with neuroendocrine tumors of the gastrointestinal tract or unknown origin.
Changes in pediatric cancer therapy led to decreased death rate and treatment-related death rate in childhood cancer survivors, evidence shows.
A study comparing enzalutamide to bicalutamide in castration-resistant prostate cancer showed that enzalutamide increased significantly progression-free survival.
Chemotherapy-induced peripheral neuropathy is a common side effect for women cancer survivors, a new study reveals.
A new study identifies the gaps in post-treatment care for adolescent and young-adult Hodgkin lymphoma survivors.
Treating patients with castration-resistant metastatic prostate cancer with docetaxel following abiraterone resulted in a 50% reduction in prostate specific antigen.
Treating high-risk prostate cancer patients with anti-androgen therapy using daily bicalutamide improved their overall survival, a new research reveals.
Starting adapted fitness routines during treatment rather than waiting until afterward proved to be more beneficial for cancer patients, a new analysis reveals.
Pancreatic cancer surgery patients treated also with radiotherapy together with chemotherapy lived longer, a new research found.
A study comparing afatinib than gefitinib as first-line treatment in patients with advanced lung cancer showed the effectiveness of afatinib.
Studying medical expenditures and productivity losses in cancer patients, scientists report that the financial burden is influenced by age and cancer site.
A new study comparing the current standard care for renal cell carcinoma, everolimus and cabozantinib reveals the increased benefit of cabozantinib.
A new study reveals that childhood cancer treatments, such as certain chemotherapy and radiation, may increase the risk of heart damage in cancer survivors.
A study comparing surgical to chemical castration in men with metastatic prostate cancer showed that surgical castration leads to less adverse effects.
Breast cancer patients who achieved ovarian suppression with the hormonal drug triptorelin had more chances to recover ovarian function, a new study shows.
Counting the symptoms of breast cancer-related lymphedema appeared to be diagnostically relevant and a cost-effective initial screening tool for lymphedema.
According to the largest randomized trials in ovarian cancer, screening may reduce ovarian cancer mortality, as it can detect the disease sufficiently early.
Afatinib appears to be more effective than gefitinib for the treatment of patients with EGFR-activating mutations in advanced lung cancer, a new study shows.
The immunotherapy drug pembrolizumab could benefit patients with refractory lung cancer selected for PD-L1 expression, a new study shows.
Patients with advanced cancer choose to continue working after their diagnosis. However, many aspects of the disease prevent them from doing so.
Patients with difficult-to-treat and advanced head and neck cancer have more treatment options with immunotherapy and targeted therapy.
Focusing on patient-reported health status, scientists reported that the mental health of a bladder cancer patient prior to surgery affects postoperative outcomes.
The novel immunotherapy pembrolizumab was approved by the U.S. FDA as first-line treatment for metastatic melanoma.
In a recent study assessing the physical, psychological, social and spiritual wellbeing of thyroid cancer survivors, a “poor” quality of life was reported.
A new study revealed the potent humanin analogue (HNG) may help cancer patients on chemotherapy avoid infertility and a weakened defense system.
A new report provides evidence and key recommendations for medical clinicians to improve cancer prevention and treatment of people with mental illness.